General Information of Drug (ID: DM3G0OP)

Drug Name
CAR-T cells targeting CD34 Drug Info
Indication
Disease Entry ICD 11 Status REF
Acute myeloid leukaemia 2A60 Preclinical [1]
Cross-matching ID
TTD Drug ID
DM3G0OP

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
AMR-001 DMGE8FK Heart failure BD10-BD13 Phase 2 [2]
CART-34 cells DMRNIB9 Acute myeloid leukaemia 2A60 Phase 1 [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Hematopoietic progenitor cell antigen CD34 (CD34) TTZAVYN CD34_HUMAN CAR-T-Cell-Therapy [1]

References

1 ClinicalTrials.gov (NCT03473457) CAR-T Cells Therapy in Relapsed/Refractory Acute Myeloid Leukemia
2 National Cancer Institute Drug Dictionary (drug id 743421).
3 ClinicalTrials.gov (NCT03291444) CAR-T Cells Combined With Peptide Specific Dendritic Cell in Relapsed/Refractory Leukemia/MDS